Join a supportive team to support Ethics and Governance submissions for study start-up across a diverse portfolio of clinical trials. This newly created role, available due to organisational growth, offers the opportunity to build your clinical research career in a purpose-driven organisation.
Cancer Trials Australia (CTA) is a not-for-profit member-based organisation comprising of 33 clinical sites and 3 medical research institutes across Australia and New Zealand. We support the administration and management of clinical trials across metropolitan and regional hospitals, working closely with clinical research sites, sponsors and Contract Research Organisations (CROs) to help patients access appropriate clinical trials as quickly as possible. CTA is committed to developing internal talent and fostering a workplace culture grounded in compassion and purpose.
CTA is committed to equal employment opportunity and ethical practices. We value the diversity of our people and the contribution this brings to our workplace. We support a culture of equity, inclusion, and respect, and welcome applications from all people.
As part of the Operations team, you will be part of a collaborative and supportive team that is responsible for providing high levels of administrative and customer service support. This role will coordinate ethics and governance submissions of clinical trials to ensure their effective and timely approval and implementation.
Our Ethics Submission Specialists, as this role is known internally, liaise closely with Research teams (Study Coordinators, Principal Investigators, and Research Unit Managers) at Clinical Research Sites, as well as staff from Human Research Ethics Committees and Research Governance Offices. You will also nurture strong relationships with local and global CRO’s, as well as national and international biotechnology and pharmaceutical companies.
In this role you will:
The ideal candidate will have excellent administration and communication skills with a strong focus on customer service. You will be a team player, who thrives in delivering quality outcomes to clients.
Qualifications and experience:
Candidates located beyond our Melbourne office-based region are encouraged to apply, as fully remote arrangements may be considered for this role within Australia.
To view the associated position description, please copy and paste the link below into your web browser:
https://cancertrialsaustralia.com/wp-content/uploads/2026/09/Ethics-Submission-Specialist_PD-2025.pdf
For any further queries about this opportunity email: employment@ctaust.org
Please note, the successful applicant will be required to provide a current National Police Check.
Closing date for applications: Tuesday, 6 October 2026 at 5pm
Only shortlisted candidates will be contacted within a week of the closing date.
At CTA, our values guide how we work with each other, our members, and the broader clinical research community.
Shared Purpose | Integrity | Collaboration | Adaptability | Compassion
For over 20 years, Cancer Trials Australia (CTA) has played a crucial role in providing site administration and management services for clinical trials, spanning feasibility through to close-out, covering start-up regulatory submissions, budget and contract negotiations, amendments, and billing on behalf of our hospital members.
Having supported the administration of 2,200+ clinical trials, sponsored by 350+ biotechnology and pharmaceutical companies, that have recruited in excess of 14,000 Australian patients, CTA is focused on its service provision to ensure that studies are managed efficiently.
In addition to our clinical trial administration services, we have been involved in a number of significant sector development initiatives since our inception, including; implementing the Mutual Acceptance Program (MAP) across our Members; assisting with the development of a standard clinical trial agreement template for sponsored trials now known as the Medicines Australia Standard Clinical Trial Research Agreement template; the development of a First Time in Human (FTIH) protocol to enable Human Research Ethics Committees (HRECs) to strengthen their capacity to review Early Phase research; developing a pre-screening protocol, to allow patients to be screened at their local hospital for clinical trial participation at another hospital; convening a Phase 1 Fellowship Program to increase capacity for sites to coordinate FTIH trials; administering a range of projects aimed at increasing clinical trial education and capacity building through Victorian Comprehensive Cancer Centre initiatives and most recently the coordination of the Australian Clinical Trials Education Centre (A-CTEC) to support a dedicated Learning Management System (LMS) hosting a suite of evidence-based, interactive clinical trial education opportunities for Australian clinical trial staff.
